Automated Clinical Study Reports

The most challenging phase of bringing a drug to market is the Human Drug Trial in Phase III, where the potential drug is trialed among a group of human volunteers. Following, the clinicians must write the “Clinical Study Report” (CSR) – one of the most expensive and time consuming aspects of bringing a drug to market.

Thanks to AI-Powered Natural Language Generation (NLG), over 30% of the CSR report can now be automated!

integrations

30-40%

Time saving for a report

"Using AX NLG software means that CSR reports are written between 30% and 40% faster."
Robert Weissgraeber
CTO & Managing Director AX Semantics

Natural Language Multilingual Reports in a Fraction of the Time

NLG connects to the clinical study database and generates perfect, auditable reports instantly (in 110 languages). 

AX Semantics is an AI Powered Natural Language Generation tool with a difference. Unlike conventional NLG tools that take months or years to develop, AX was built from the ground up to be what we call “AI-As-A-Service”. This means that the tool can be operational in days or weeks instead of months or years. It is also a software that can be used by medical writers themselves. And AX Semantics has all the relevant HIPPA processes to help Pharma companies remain compliant and stay certified.

The Impact of NLG on Pharmaceutical Companies

Bringing a drug to market earlier means saving more lives.

By using Natural Language Generation you can save 30-40% time during the drafting of a report.

Speeding the time to go to market means grabbing market share.

By speeding the time to go to market, Natural Language Generation changes the economic balance that pharmaceutical companies base their R&D and M&A investment on and create a competitive edge.

Download free Executive Summary about how to automate CSR with NLG:

executive summary

Read more in our Blog

Want to try? Check if it works for you!

See if our software will work well for you.